Kamada Ltd.

KMDA Healthcare Drug Manufacturers Specialty & Generic

Kamada Ltd.’s revenue for fiscal 2025 (year ended December 2025) was $180.5 million, up 12.1% from fiscal 2024. In the quarter to June 2026, revenue grew 22.7%, EPS grew 23.1%, free cash flow grew 165.7% and total debt fell 38.8%, each against the same quarter a year earlier. Revenue growth for three consecutive years.

7.77 0.06 −0.77%
Market cap
$451.7M
P/E
20.4×
Fwd P/E
0.0×
Dividend yield
5.41%
F-score
7/9
Altman Z
3.33
Beneish M
−2.35
Dividend safety
50/100

A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.

Dec '16 Dec '17 Dec '18 Dec '19 Dec '20 Dec '21 Dec '22 Dec '23 Dec '24 Dec '25
Cash and Short Term Investments
28.63 43.02 50.59 73.91 109.27 18.59 34.26 55.64 78.44 75.47
Receivables
22.85 32.79 30.98 26.48 26.63 44.03 35.96 25.84 27.09 32.66
Inventory
25.59 21.07 29.32 43.17 42.02 67.42 68.79 88.48 78.82 84.94
Total current assets
77.08 96.88 110.89 143.56 177.91 130.04 139.01 169.96 184.35 193.08
Property, Plant, Equpment (Net)
22.58 25.18 25.00 24.55 25.68 26.31 26.16 28.22 36.25 41.37
Goodwill and Intangible Assets (Total)
0.33 — 0.00 0.29 1.56 154.19 147.44 30.31 30.31 30.31
Long Term Assets (Tax, Deferred)
— — 2.05 1.31 — — — — 0.49 —
Long-term assets (Other)
0.04 0.05 0.17 0.35 3.63 159.22 154.65 118.65 111.25 105.06
Total non-current assets
22.62 25.23 27.23 30.24 32.75 188.62 183.37 184.95 187.91 185.64
Total Assets
99.70 122.11 138.12 173.80 210.67 318.67 322.38 354.91 372.26 378.71
Accounts Payable
21.89 23.86 22.55 30.64 23.66 32.25 40.50 33.07 37.41 35.35
Current Part of Debt
0.41 0.61 0.45 0.49 0.24 20.62 34.15 15.00 10.18 9.92
Current Revenue (Deferred)
4.90 4.93 0.46 0.59 — 0.04 0.04 0.15 0.17 —
Total current liabilities
27.21 29.40 23.57 32.74 24.97 54.06 75.71 49.59 49.39 47.39
Long Term Debt (Total)
1.36 1.37 0.69 0.26 0.04 17.41 12.96 — — —
Non-current Revenue (Deferred)
3.66 0.71 0.67 0.23 2.03 0.02 — — — —
Pension and Post-Retirement Liabilities
0.72 1.14 0.79 1.27 1.41 1.28 0.67 0.62 0.51 0.67
Long Term Tax Liability (Deferred)
— — (2.13) (1.45) 1.42 — — — — 1.65
Non-current Liabilities (Other)
0.72 1.14 0.80 1.16 1.56 65.92 54.84 53.23 53.46 50.49
Total non-current liabilities
5.75 3.22 2.17 5.74 7.06 87.79 70.65 61.29 63.40 62.25
Total liabilities
32.95 32.62 25.74 38.48 32.03 141.84 146.36 110.89 112.79 109.64
Additional Paid In Capital
162.67 177.87 179.15 180.82 209.76 210.20 210.50 265.85 266.93 268.28
Common Stock (Net)
9.32 10.40 10.41 10.43 11.71 11.73 11.73 15.02 15.03 15.08
Retained Earnings
(111.46) (104.56) (83.02) (61.07) (43.93) (46.16) (48.48) (40.20) (25.74) (17.07)
Shareholders Equity (Other)
6.22 5.78 5.84 5.15 1.11 1.06 2.28 3.35 3.24 2.78
Common Equity (Total)
66.74 89.49 112.38 135.32 178.64 176.82 176.02 244.02 259.46 269.07
Shareholders Equity (Total)
66.74 89.49 112.38 135.32 178.64 176.82 176.02 244.02 259.46 269.07
Shareholders Equity and Liabilities (Total)
99.70 122.11 138.12 173.80 210.67 318.67 322.38 354.91 372.26 378.71
Shares (Common)
36.42 40.26 40.30 40.35 44.74 44.80 44.83 57.48 57.51 57.69
Shareholders Equity (Tangible)
66.74 89.49 112.38 135.32 178.64 176.82 176.02 213.71 229.15 238.76
Net Debt
(26.86) (41.03) (49.45) (73.16) (108.99) 19.44 12.86 (40.64) (68.25) (65.55)
Total Debt
1.78 1.98 1.14 0.75 0.27 38.02 47.12 15.00 10.18 9.92

Fold the line items

In millions of $ except per-share values · columns are period end dates